The key difference lies in their mechanisms: Retatrutide activates three metabolic receptors (GIP, GLP-1, and glucagon) while Tirzepatide activates two (GIP and GLP-1)
Trial data suggests retatrutide produces greater weight loss than tirzepatide (24.2% vs 20.9%) or semaglutide (24.2% vs 14.9%)
The presence of multiple similar domain names raises questions about brand consistency
Freezer-Friendly Options (Your Emergency Backup) Having a freezer stash is essential on GLP-1 medications because your appetite and tolerance fluctuate from week to week, especially after dose increases
During early treatment, many people find they cannot tolerate hot foods, large portions, or high-fat meals
Pancreatitis : An association between GLP-1-based therapies and acute pancreatitis has been observed, though a definitive causal relationship has not been established